Efficacy of botulinum toxin for spasticity management in neurorehabilitation

International Journal of Therapy and Rehabilitation

Volumn 11, Issue 5, 2004, Pages 211-218

  Kulkarni, Jai ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Botulinum toxin; Physiotherapy; Rehabilitation; Spasticity

Indexed keywords

EID: 70349222521     PISSN: 17411645     EISSN: 1759779X     Source Type: Journal    
DOI: 10.12968/ijtr.2004.11.5.13341     Document Type: Article

References (31)

1. Aoki KR, Guyer B (2001) Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 8(S5): 21
2. Aoki KR, Ismail M, Tang-Liu D, Brar B, Wheeler LA (1997) Botulinum toxin type A: from toxin to therapeutic agent. Eur J Neurol 4(l2): S1-3
3. Bakheit AMO, Pittock S, Moore AP et al (2001) A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 8(6): 559-65
4. Bolton MP, Kulkarni JR (1997) A battery-powered constant current stimulator for motor end-point detection. Med Eng Phys 8: 755-8
5. Boyd RN, Hays RM (2001) Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 8(5): 1-20
6. Burbaud P, Wiart L, Dubos JL et al (1996) A randomised, double-blind placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatr 61: 265-9
7. Davis D, Bahman J (1993) Significant improvement of stiffperson syndrome after paraspinal injection of botulinum toxin A. Mov Disord 8(3): 371-3
8. Gormley ME Jr, O’Brien CF, Yablon SA (1997) A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve (suppl): S169-75
9. Greene P, Kang U, Fahn S et al (1990) Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 40: 1213-18
10. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL (1999) Reliability of the Tone Assessment Scale and the Modified Ashworth Scale as clinical tools for assessing post-stroke spasticity. Arch Phys Med Rehabil 80(9): 1013-16
11. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH (1996) Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 27(3): 455-60
12. Hyman N, Barnes M, Bhakta B et al (2000) Botulinum toxin (dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatr 68(6): 707-12
13. Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186-94
14. Jankovic J, Schwartz K (1991) Botulinum toxin treatment of tremors. Neurology 41(8): 1185-8
15. Jankovic J, Schwartz KS (1993) Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 43: 834-6
16. Kulkarni J, Deshpande M (2000) Botulinum toxin: spasticity therapy in neuro rehabilitation. Prog Neurol Psychiatry 4(3): 30-5
17. Lees AJ (1992) Botulinum toxin; useful in adult onset focal dystonias. Br Med J 305: 1169-70
18. Mathew NT, Kaup AO (2002) The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol 4(5): 365-73
19. Milanov IG (1992) Mechanisms of baclofen action on spasticity. Acta Neurol Scand 85: 305-10
20. Münchau A, Bhatia KP (2000) Uses of botulinum toxin injection in medicine today. Br Med J 320: 161-5
21. Reichel G (2001) Botulinum toxin for the treatment of spasticity in adults. J Neurol 248(suppl. 1): 25-7
22. Rosche J (2002) Treatment of spasticity. Spinal Cord 40(6): 261-2
23. Rosche J, Rub K, Niemann-Delius B, Mauch E, Kornhuber HH (1996) Effects of physiotherapy on F-wave-amplitudes in spasticity. Electromyogr Clin Neurophysiol 36(8):509-11
24. Rosche J, Paulus C, Maisch U, Kaspar A, Mauch E, Kornhuber HH (1997) The effects of therapy on spasticity utilizing a motorized exercise-cycle. Spinal Cord 35(3): 176-8
25. Sheean G, Barnes MP (1998) Spasticity Rehabilitation. Churchill Communications Europe Ltd, London
26. Simpson DM (1997) Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve 6: S169-75
27. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA, Calne DB (1990) Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 28(4): 512-15
28. Stell R, Thompson PD, Marsden CD (1988) Botulimun toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatr 51: 920-3
29. Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2(8501): 245-7
30. Wade DT, De Jong BA (2000) Recent advances in rehabilitation. Br Med J 320: 1385-8
31. Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43(9): 1715-18